Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time-series analysis.
Yao-Fan FangJia-Rou LiuShu-Hao ChangChang-Fu KuoLai-Chu SeePublished in: Immunity, inflammation and disease (2022)
In patients with RA, the introduction of DMARDs was associated with stable adverse events and mortality rates. Moreover, the introduced new treatment for RA exhibited a good safety profile.